Eron, Joseph J.

Prevention of HIV-1 infection with early antiretroviral therapy.

Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV Research and Treatment

Cited by 6,873

Antiretroviral therapy for the prevention of HIV-1 transmission.

Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2016) · New England Journal of Medicine

HIV/AIDS Research and InterventionsHIV Research and Treatment

Cited by 1,700

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel

Saag, M. S., Benson, C. A., Gandhi, R. T., Hoy, J. F., Landovitz, R. J., Mugavero, M. J., Sax, P. E., Smith, D. M., Thompson, M. A., Buchbinder, S. P., et al. (2018) · JAMA

HIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions

Cited by 698

Antiretroviral drugs for treatment and prevention of HIV in adults: 2024 recommendations of the International Antiviral Society-USA Panel

Gandhi, R. T., Landovitz, R. J., Sax, P. E., Smith, D. M., Springer, S. A., Günthard, H. F., Thompson, M. A., Bedimo, R. J., Benson, C. A., Buchbinder, S. P., et al. (2025) · JAMA

HIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions

Cited by 265

Cabotegravir plus rilpivirine, once a day, after induction with cabotegravir plus nucleoside reverse transcriptase inhibitors in antiretroviral-naive adults with HIV-1 infection (LATTE): a randomised, phase 2b, dose-ranging trial

Margolis, D. A., Brinson, C. C., Smith, G. H. R., de Vente, J., Hagins, D. P., Eron, J. J., Griffith, S. K., Clair, M. H. S., Stevens, M. C., Williams, P. E., et al. (2015) · The Lancet Infectious Diseases

HIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions

Cited by 204

Prevalence and Comorbidity of Psychiatric Diagnoses Based on Reference Standard in an HIV+ Patient Population

Gaynes, B. N., Pence, B. W., Eron, J. J., & Miller, W. C. (2008) · Psychosomatic Medicine

HIV/AIDS Research and InterventionsHIV-related health complications and treatments

Cited by 143

Prevalence and Factors Associated with Hazardous Alcohol Use Among Persons Living with HIV Across the US in the Current Era of Antiretroviral Treatment

Crane, H. M., McCaul, M. E., Chander, G., Hutton, H., Nance, R. M., Delaney, J. A. C., Merrill, J. O., Lau, B., Mayer, K. H., Mugavero, M. J., et al. (2017) · AIDS and Behavior

Substance Abuse Treatment and OutcomesHIV, Drug Use, Sexual Risk

Cited by 125

HIV infection, immunosuppression, and age at diagnosis of non-AIDS-defining cancers

Shiels, M. S., Althoff, K. N., Pfeiffer, R. M., Achenbach, C. J., Abraham, A. G., Castilho, J., Cescon, A., D’Souza, G., Dubrow, R., Eron, J. J., et al. (2017) · Clinical Infectious Diseases

Viral-associated cancers and disordersHIV/AIDS Research and Interventions

Cited by 95

The prevalence of mental health disorders in people with HIV and the effects on the HIV care continuum

Lang, R., Hogan, B., Zhu, J., McArthur, K., Lee, J., Zandi, P., Nestadt, P., Silverberg, M. J., Parcesepe, A. M., Cook, J. A., et al. (2023) · AIDS

HIV/AIDS Research and InterventionsHIV, Drug Use, Sexual Risk

Cited by 75

Expression of p16INK4a as a biomarker of T‐cell aging in HIV‐infected patients prior to and during antiretroviral therapy

Nelson, J. A. E., Krishnamurthy, J., Menezes, P., Liu, Y., Hudgens, M. G., Sharpless, N. E., & Eron, J. J. (2012) · Aging Cell

HIV Research and TreatmentTelomeres, Telomerase, and Senescence

Cited by 66